Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2016 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2016 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia

  • Authors:
    • Chao Deng
    • Yuanyuan Sun
    • Haitian Fu
    • Sixiu Zhang
    • Jinghua Chen
    • Xin Xu
  • View Affiliations / Copyright

    Affiliations: Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China, School of Pharmaceutical Science, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China, Cardiovascular Department, Wuxi No. 2 People's Hospital, Wuxi, Jiangsu 214002, P.R. China
  • Pages: 4857-4864
    |
    Published online on: October 4, 2016
       https://doi.org/10.3892/mmr.2016.5794
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In the present study, the physiochemical and biological properties of crude mycelium polysaccharide (CMCP) and purified mycelium polysaccharide (MCP) extracted from the Tremella aurantialba mycelium were investigated. A series of physiochemical properties were determined, including the total sugar, uronic acid and protein content, monosaccharide composition and structure, and molecular weight. The reducing power and scavenging activity of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl radicals were determined to investigate the antioxidant activity of CMCP and MCP. Furthermore, the immunostimulatory activity of the polysaccharides was evaluated by detecting the effects of CMCP and MCP on proliferation, nitric oxide (NO) production and cytokine secretion by RAW264.7 cells. The chemical analysis revealed that MCP had a molecular weight of 4.3x104 g/mol and was composed primarily of D‑glucose, D‑galactose and D‑mannose. The total carbohydrate contents of MCP and CMCP were 86.59 and 11.92%, respectively. Compared with CMCP, MCP demonstrated improved antioxidant properties. In addition, MCP induced RAW264.7 macrophage proliferation, NO production and secretion of tumor necrosis factor‑α, interleukin (IL)‑1 and IL‑6. These findings suggest that the total carbohydrate content may contribute to the improvement of antioxidant and immunostimulatory activities of MCP.

Introduction

Tremella aurantialba, a wood-inhabiting host-specific fungus, has been commonly used in traditional Chinese medicine (1). Numerous studies have analyzed polysaccharides extracted from its mycelium and fruit body as well as the crude extract of the fermentation broth (2–4). These extracted polysaccharides have been demonstrated to have pharmacological properties, including antidiabetic, antitumor and antihyperlipidemic activities (5–7), as well as immunostimulatory effects (8). Kiho et al (9) revealed that a polysaccharide isolated from T. aurantialba produced significant antidiabetic effects, and decreased serum cholesterol, free fatty acid and triglyceride levels in diabetic mice. Furthermore, polysaccharides extracted using hot water and ethanol (70%) from T. aurantialba exerted potent inhibitory effects on the growth of prostate cancer cell lines, including LNCaP and PC-3 (10). Therefore, T. aurantialba polysaccharides may be valuable sources of food and pharmaceutical agents.

To date, the extraction of polysaccharides from T. aurantialba has not been commercially feasible. This is largely due to a long cultivation cycle and low production, as well as sensitivity to seasons and insects. To address these issues, liquid fermentation technology has been adopted to increase the yield of T. aurantialba and its polysaccharide content.

Numerous studies have investigated the biological functions of mycelium polysaccharides from T. aurantialba in cardiovascular and cerebral diseases, diabetes mellitus, and in blood fat and pressure control (2,11,12). However, little is known about the antioxidant and immunostimulatory activities of mycelium polysaccharides. In the present study, crude mycelium polysaccharide (CMCP) and purified mycelium polysaccharide (MCP) were isolated from the mycelia of T. aurantialba using liquid fermentation technology. The antioxidant activities of these polysaccharides were evaluated by determining their reducing power, and 2,2-diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl radical scavenging ability. Furthermore, immunostimulatory effects were analyzed by investigating cellular proliferation, and the release of nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukin (IL)-1 and IL-6 by RAW264.7 macrophages.

Materials and methods

Materials

T. aurantialba was purchased from The Agricultural Culture Collection of China (Beijing, China). The RAW264.7 mouse macrophage cell line was obtained from the cell bank of The Chinese Academy of Sciences (Shanghai, China). Dimethyl sulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), DPPH, and lipopolysaccharide (LPS) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were obtained from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). Standard monosaccharides including glucose, xylose, rhamnose, arabinose, mannose and galactose were obtained from Sangon Biotech Co., Ltd. (Shanghai, China). Sephadex G-100 was purchased from GE Healthcare Life Sciences (Chalfont, UK).

Incubation and fermentation of T

aurantialba. T. aurantialba was initially cultured on potato dextrose agar (PDA) slant tube medium containing 20% potato, 2% glucose and 2% agar, and then transferred to PDA plates. Following incubation at 28°C for 14 days, sections of T. aurantialba mycelium from PDA plates were transferred to liquid medium containing 20% potato, 2% glucose, 0.3% KH2PO4, 0.15% MgSO4·7H2O and 0.01–0.02 mg/ml vitamin B1. Fermentation was performed in a flask shaken at 220 rpm for 14 days at 28°C.

Preparation and purification of polysaccharides from T. aurantialba mycelia

Mycelia were obtained from culture broths using a Buchner funnel and air-dried. Extraction was performed by incubating mycelia with 1.25 mol/l NaOH solution containing 0.05% (w/v) NaBH4 at room temperature for 4–6 h. Following pumping filtration to remove mycelia fragments, the residues were neutralized with 2 mol/l acetic acid and centrifuged at 4,000 × g for 30 min at room temperature. Supernatants were collected, concentrated to 1/5 of the original volume and precipitated with four volumes of 95% (v/v) ethanol solution. The precipitate was collected and washed with deionized water. Subsequently, the solution was deproteinated by mixing with an equal volume of Sevage reagent (chloroform:n-butanol [4:1 (v/v)]) and centrifuging at 4,000 × g for 30 min at 4°C. This solution was then precipitated with four volumes of 95% (v/v) ethanol solution. The precipitate was freeze-dried and designated as CMCP.

CMCP was dissolved in deionized water (5 mg/ml) and purified by gel permeation chromatography using a Sephadex G-100 column (1×30 cm). Aliquots (1 ml) were applied to the column, which was eluted with 0.1 mol/l NaCl at a flow rate of 0.75 ml/min, with each tube collecting 0.75 ml effluent. The polysaccharide content of effluent was determined by the phenol-sulfuric acid method (13). The elution curve was obtained indirectly using the number of collecting tubes as the abscissa and the absorbance of the effluent-phenol-sulfuric acid reaction system as the ordinate (Fig. 1). Collected liquid from the single peak was merged and dialyzed against deionized water in a cellulose dialysis tube. The solution was freeze-dried in a vacuum to obtain the purified polysaccharide (MCP).

Figure 1.

Elution curve of mycelia polysaccharide. The elution curve was obtained indirectly with the abscissa representing the number of collecting tubes and the ordinate representing the absorbance of the effluent-phenol-sulfuric acid reaction system. Liquid collected from the single peak was merged and dialyzed against deionized water in a cellulose dialysis tube. The solution was freeze-dried in a vacuum to obtain the purified mycelium polysaccharide. OD, optical density.

Chemical analysis of polysaccharides
Determination of total sugar, uronic acid and protein content

The total sugar content of CMCP and MCP was analyzed using the phenol-sulfuric acid method (13), while the uronic acid and protein content were determined by the carbazole-sulfuric acid and Coomassie brilliant blue methods (14), respectively.

Monosaccharide analysis of MCP

MCP (20 mg) was hydrolyzed with 1 M H2SO4 at 100°C for 5 h in a thermostatic water bath (HH-8; Jintan Xinxin Experimental Instrument Co., Ltd., Changzhou, China). The hydrolysate was neutralized with excess BaCO3. The obtained solution was centrifuged at 2,600 × g for 15 min at room temperature. Subsequently, the free monosaccharide was obtained from the supernatant by drying in a vacuum oven at 45°C. The dried monosaccharide (10 mg) was added to hydroxylamine hydrochloride (10 mg), inositol (2 mg) and pyridine (0.5 ml) and incubated at 90°C for 30 min. The solution was then mixed with acetic anhydride (0.5 ml) in a constant temperature water bath at 90°C for 30 min. The monosaccharide composition was determined by gas chromatography analysis using the methods described previously (15).

Determination of molecular weight of MCP

The molecular weight (MW) of samples was determined by gel permeation chromatography (GPC) using a method described in our previous study (16). In brief, the samples were separated on an Agilent 1200 Liquid Chromatography system equipped with a G1310A pump, a PL aquagel-OH column (7.5×300 mm; Agilent Technologies, Inc., Santa Clara, CA, USA.) and a differential refractive index detector (RID; G1362A). The column and RID detector temperature was maintained at 25°C, the flow rate of the mobile phase (0.1 M NaNO3) was 0.8 ml/min, and all solutions were filtered with 0.45 µm syringe filter. The column was calibrated with dextran standards of varying molecular weights (10,000, 41,100, 84,400, 133,800, 275,900 and 606,200 Da).

Infrared spectroscopy of MCP

Fourier transform infrared (FTIR) spectroscopy of MCP (2 mg) mixed with dry KBr (200 mg) was performed at room temperature in the 4000 cm-1 to 500 cm-1 region (Thermo Fisher Scientific, Inc.).

Antioxidant activity assay of polysaccharides Determination of reducing power

The reducing power of CMCP and MCP was determined according to a previously described method (17) with slight modifications. Briefly, various concentrations of polysaccharides (50, 100, 200, 400 or 1,000 µg/ml) in 1 ml distilled water were mixed with phosphate buffer [2.5 ml, 2 M (pH 6.6)] and potassium ferricyanide [K3Fe (CN)6; 0.25 ml, 1% (w/v)]. Following an incubation at 50°C for 20 min, 0.5 ml trichloroacetic acid [10% (w/v)] was added to the mixture to terminate the reaction. The solution was centrifuged at 3,000 × g for 10 min at room temperature. An aliquot of 1.5 ml supernatant was collected, mixed with 0.1 ml FeCl3 [0.1%, (w/v)] and 3 ml deionized water, and incubated at room temperature for 5 min. The absorbance of polysaccharides was measured at a wavelength of 700 nm using an ultraviolet visible spectrophotometer (UVmini-1240; Shimadzu International Trading Co., Ltd, Shanghai, China).

DPPH scavenging activity

DPPH radical scavenging activity was determined according to a previously described method (18) with slight modifications. A total of 1 ml polysaccharide (50, 100, 200, 400 or 1,000 µg/ml) was added to a 0.004% ethanol solution of DPPH (3.0 ml), and incubated at room temperature for 30 min in the dark. In the control group, 95% ethanol replaced the DPPH solution, while distilled water was used as the blank. The absorbance of each reaction mixture was measured at a wavelength of 517 nm using an ultraviolet visible spectrophotometer (Shimadzu International Trading Co., Ltd.). The DPPH scavenging activity was calculated as follows:

Scavenging ability (%)=[1-(Asample517-Acontrol517)/Ablank517] ×100

Hydroxyl radical scavenging activity

The hydroxyl radical scavenging activity of the polysaccharide was determined using Fenton's reaction, as previously described (19). The reaction mixture consisted of 1 ml polysaccharide (50, 100, 200, 400 or 1,000 ug/ml), 0.9 ml EDTA-FeSO4 (0.15 mM), 0.5 ml H2O2 (8.8 mM) and 0.5 ml salicylic acid (9 mM). In the control group, water replaced the sample and sodium phosphate replaced the H2O2, while water was used as the blank. Following incubation at 37°C for 60 min, the absorbance of samples was measured at a wavelength of 510 nm. The hydroxyl radical scavenging activity was calculated as follows:

Scavenging ability (%)=[1-(Asample510-Acontrol510)/Ablank510] ×100

RAW264.7 cell culture

RAW264.7 cells were cultured in DMEM supplemented with 10% FBS, in a water-jacketed incubator (Thermo Fisher Scientific, Inc.) at 37°C with 5% CO2 in a humidified atmosphere. The medium was replaced every day, and the cells were passaged every second day. Cells were used in subsequent experiments when 80% confluency was reached.

MTT assay

An MTT assay was performed as previously described (20) to determine the effect of polysaccharides on the proliferation of RAW264.7 cells. Briefly, RAW264.7 cells, at a density of 5×104/ml, were seeded in 96-well plates and incubated with 100 µl test samples at various concentrations (50, 100 or 200 µg/ml) for 48 h. Cells treated with LPS (1 µg/ml) served as a positive control, while cells treated with medium alone were used as a negative control. Subsequently, 10 µl of MTT (5 mg/ml) was added to each well and incubated for a further 4 h at 37°C. The plates were centrifuged at 1,000 × g for 5 min at room temperature. Following removal of the supernatant, 100 µl of DMSO was added to each well. Plates were agitated for 10 min to dissolve the produced formazan crystals, and the optical densities were measured at a wavelength of 570 nm using a microplate reader.

Influence of polysaccharide on NO secretion of RAW264.7

Nitrite accumulation served as a marker of NO production in culture medium, and was measured using the Griess reaction (21). RAW264.7 cells were seeded in 96-well plates at a density of 5×104 cells/well and incubated at 37°C and 5% CO2 in a humidified atmosphere for 6 h. Cells were treated with polysaccharides (50, 100 or 200 µg/ml), LPS (positive control) or culture media alone (negative control). Nitrite production was determined using a Griess kit (Beyotime Institute of Biotechnology, Shanghai, China) according to the manufacturer's instructions.

Influence of polysaccharide on cytokine secretion by RAW264.7 cells

The production of IL-1, IL-6 and TNF-α by RAW264.7 cells was detected using enzyme-linked immunosorbent assay kits (cat. nos. MLB00C, M6000B and MTA00B, respectively; R&D Systems, Inc., Minneapolis, MN, USA) according to the manufacturer's instructions. Cells (5×104 cells/well) were seeded in 96-well plates and treated as for the experimental, positive control and negative control groups described above.

Statistical analysis

Data analyses were performed using SPSS software version 19.0 (IBM SPSS, Armonk, NY, USA). Data are presented as the mean ± standard deviation. The results were analyzed using one-way analysis of variance followed by the least significant difference test. P<0.05 was considered to indicate a statistically significant difference.

Results

Fermentation of T. aurantialba was successful

Fig. 2 presents the growth curve of T. aurantialba in culture plates (Fig. 2A) and the growth curve of mycelium in shake-flasks (Fig. 2B). The colony of T. aurantialba was roundish, white and opaque with a matte surface. The diameter of the colony in the plate increased gradually over time, and covered the plate by day 14. In addition, the biomass of mycelium in shake-flasks increased over time, reaching 0.34 g/50 ml on the day 10, following which the biomass plateaued. Mycelium consisted of golden yellow spherical particles, with good dispersion in the liquid medium. The fermentation broth was clear, with a color that darkened gradually over time.

Figure 2.

(A) Growth curve of T. aurantialba in culture plates. The radius of the colony in the plate increased gradually over time, and covered the plate by day 14. (B) Growth curve of mycelium in shake-flask liquid cultures. The biomass of mycelium in shake-flasks increased over time, reaching 0.34 g/50 ml on day 10, at which point the biomass plateaued.

Mycelia polysaccharide were isolated and the composition analyzed

The yield of CMCP from T. aurantialba was 1.53%, the total carbohydrate content was 11.92% and the residual protein content was 21.7%. The total carbohydrate and residual protein content of MCP were 86.59 and 3.5%, respectively, following deproteinization using the Sevage method and purification on a Sephadex G-100 column. The uronic acid content was 16.4% and the molecular weight of MCP as determined by GPC was 4.3×104 g/mol (Table I).

Table I.

Molecular weight of MCP.

Table I.

Molecular weight of MCP.

Molecular weight (×104 g/mol)

Sample Mw/Mn Mw Mn
MCP4.302.951.46

[i] MCP, purified mycelium polysaccharides; Mw, weight-average molecular weight; Mn, number-average molecular weight.

Table II presents the monosaccharide composition and content of MCP. MCP was comprised of D-glucose, D-galactose and D-mannose, with traces of D- rhamnose, D-arabinose and D-xylose.

Table II.

Monosaccharide composition of purified mycelium polysaccharides.

Table II.

Monosaccharide composition of purified mycelium polysaccharides.

Monosaccharide compositionContent (%)
Rhamnose   1.31
Arabinose   0.74
Xylose   1.36
Mannose   4.53
Glucose82.17
Galactose   9.89

The FTIR spectrum of MCP is presented in Fig. 3. The FTIR spectrum revealed a strong broad absorption peak at 3,425 cm−1 due to the O-H stretching vibration of the polysaccharide and a peak at 2,930 cm−1 due to the C-H stretching vibration. FTIR spectrum of MCP exhibited an absorption peak at 1,640 cm−1, which was a characteristic of the C=O stretching vibration. No notable C=O vibration was observed at 3,000–2,500 cm−1, suggesting that the content of uronic acid was low. In addition, an absorption peak at 890 cm−1 indicated that the polysaccharide was connected by a β-glycosidic bond.

Figure 3.

Fourier transform infrared spectrum of purified mycelium polysaccharides. The broad absorption peak was observed at 3,425 cm−1 due to the O-H bond stretching vibration of the polysaccharide. A peak at 2,930 cm−1 was observed due to the C-H bond stretching vibration, and the absorption peak at 1,640 cm−1 was characteristic of the C=O bond stretching vibration. No notable C=O vibration was observed at 3,000–2,500 cm−1, suggesting that the uronic acid content was low. In addition, an absorption peak at 890 cm−1 indicated that the polysaccharide was connected by a β-glycosidic bond. T, infrared transmittance.

Antioxidant activity of CMCP and MCP
The reducing power of MCP was greater than CMCP

As presented in Fig. 4A, the reducing power of CMCP and MCP was increased in a dose-dependent manner in the range of 50–1,000 µg/ml. The reducing power of MCP was 1.26-fold greater than that of CMCP. At 1,000 µg/ml, the maximum reducing power of CMCP and MCP was 0.18 and 0.23, respectively.

Figure 4.

Antioxidant activity of polysaccharide extracted from T. aurantialba mycelia. (A) Reducing power, (B) scavenging activity to DPPH and (C) scavenging activity to the hydroxyl of MCP and CMCP were measured. MCP exerted a greater reducing power compared with CMCP in the concentration range evaluated. Furthermore, MCP exhibited superior scavenging activities of DPPH and hydroxyl radicals compared with CMCP. *P<0.05 vs. CMCP at the same concentration. DPPH, 2,2-diphenyl-1-picrylhydrazyl; MCP, purified mycelium polysaccharides; CMCP, crude mycelium polysaccharides; OD, optical density.

DPPH scavenging activity was increased with MCP treatment compared to CMCP

As presented in Fig. 4B, a rapid increase was observed in the DPPH scavenging activity with increasing MCP concentrations (50–400 µg/ml), while this rapid increase occurred in the DPPH scavenging activity of CMCP between 50 and 200 µg/ml. At a concentration of 1,000 µg/ml, the scavenging effect of MCP and CMCP reached maximums of 35.02 and 31.84%, respectively. In addition, no significant difference was observed between MCP and CMCP at concentrations of 50–200 µg/ml. The DPPH scavenging activity of MCP was significantly greater than that of CMCP at concentrations >200 µg/ml (400 µg/ml, P=0.002; 1,000 µg/ml, P=0.008; Fig. 4B).

Scavenging activity of hydroxyl radicals was increased with MCP compared with CMCP

The hydroxyl radical scavenging activity of MCP and CMCP is presented in Fig. 4C. The scavenging activity of the hydroxyl radicals increased with increasing concentrations of MCP and CMCP, with the greatest scavenging ability at 1,000 µg/ml. The scavenging ability of MCP was significantly greater than that of CMCP at 50 and 400–1,000 µg/ml (50 µg/ml, P=0.003; 400 µg/ml, P=0.006; 1,000 µg/ml, P<0.001). No statistical difference was observed at concentrations of 100–200 µg/ml.

The difference between MCP and CMCP antioxidant activities may be due to differences in total carbohydrate content.

Immunostimulatory activity of CMCP and MCP MCP induced proliferation of RAW264.7 cells

Fig. 5 presents the effects of polysaccharides on the proliferation of RAW264.7 cells. MCP stimulated the proliferation of RAW264.7 cells at concentrations of 50–200 µg/ml (P<0.05), in a dose-dependent manner. At 200 µg/ml, MCP was more effective than the positive control. However, no stimulative effects of CMCP on RAW264.7 cell proliferation were observed at concentrations of 50–200 µg/ml (P>0.05). These results indicate that MCP, but not CMCP, significantly induced proliferation of RAW264.7 cells.

Figure 5.

Polysaccharides from T. aurantialba mycelia induced the proliferation of RAW264.7 cells. MCP stimulated the proliferation of RAW264.7 cells at concentrations of 50–200 µg/ml in a dose-dependent manner. At 200 µg/ml, MCP was more effective than the positive control. However, CMCP did not promote the proliferation of RAW264.7 cells concentrations ranging from 50 to 200 µg/ml. Data are presented as the mean ± standard deviation (n=3). *P<0.05 vs. CMCP at the same concentration; #P<0.05 vs. negative control. MCP, purified mycelium polysaccharides; CMCP, crude mycelium polysaccharides; LPS, lipopolysaccharide; OD, optical density.

High concentration of MCP and CMCP increased NO secretion by RAW264.7 cells

The effects of CMCP and MCP on NO production by RAW264.7 cells were evaluated by measuring the release of nitrite. As presented in Fig. 6, no significant increase in NO production was observed with 50 µg/ml MCP or CMCP (P>0.05). Concentrations of MCP >100 µg/ml significantly increased NO production compared with the negative control (P<0.05). Increased NO production was observed in the CMCP-treated cells only at a concentration of 200 µg/ml, and remained significantly reduced compared with MCP at the same concentration (P<0.05).

Figure 6.

Effects of polysaccharides from T. aurantialba mycelia on NO production in RAW264.7 cells. No significant increase in NO production was observed with 50 µg/ml MCP or CMCP. Concentrations of MCP >100 µg/ml significantly increased NO production when compared with the negative control. Increased NO production was observed in the CMCP-treated cells only at a concentration of 200 µg/ml, and remained significantly reduced compared with MCP at the same concentration. Data are presented as the mean ± standard deviation (n=3). *P<0.05 vs. CMCP at the same concentration; #P<0.05 vs. negative control. NO, nitric oxide; MCP, purified mycelium polysaccharides; CMCP, crude mycelium polysaccharides; LPS, lipopolysaccharide.

MCP greatly increased cytokine secretion by RAW264.7 cells

The effects of MCP and CMCP on the production of TNF-α (Fig. 7A), IL-1 (Fig. 7B) and IL-6 (Fig. 7C) by RAW264.7 cells were investigated. Cytokine levels were significantly upregulated in cells treated with 100 and 200 µg/ml MCP compared with those in the negative control group (P<0.05). CMCP did not induce production of IL-1 or −6 at the concentrations tested (P>0.05); however, it did stimulate TNF-α secretion at 200 µg/ml (P<0.05), indicating that CMCP has a reduced potency compared with MCP. These results indicate that the effects of polysaccharides on macrophage activation may be associated with the total carbohydrate content in MCP and CMCP.

Figure 7.

Effects of polysaccharides from T. aurantialba mycelia on the production of various cytokines in RAW264.7 cells. (A) TNF-α production (B) IL-1 production and (C) IL-6 production were measured by enzyme-linked immunosorbent assay. Each experiment was repeated in triplicate. Cytokine levels were significantly upregulated in cells treated with 100 and 200 µg/ml MCP compared with those in the negative control group. CMCP did not induce the production of IL-1 or IL-6 at all concentrations tested. However, CMCP stimulated TNF-α secretion at 200 µg/ml, which indicates that CMCP has a reduced potency compared with MCP. Data are presented as the mean ± standard deviation (n=3). *P<0.05 vs. CMCP at the same concentration; #P<0.05 vs. negative control. MCP, purified mycelium polysaccharides; CMCP, crude mycelium polysaccharides; LPS, lipopolysaccharide; TNF-α, tumor necrosis factor-α; IL, interleukin.

Discussion

The composition and structure of polysaccharides from T. aurantialba have been reported to be closely associated with their biological properties. Biological activities may be affected by numerous factors, including diverse monosaccharide composition, glycosidic bond type and molecular weight, as well as molecular conformation. Kiho et al (22) reported that the polysaccharide TAP from T. aurantialba comprised mannose, xylose, glucuronic acid and glucose, and exhibited potent hypoglycemic activity, which was the result of non-reducing terminal α-D-mannopyranosyl residues. Furthermore, the specific structure of TAP contributed to its effect on a key hepatic enzyme and plasma cholesterol levels in healthy and diabetic mice (22,23). In the present study, chemical analysis indicated that MCP obtained by fermentation was composed primarily of D-glucose, D-galactose and D-mannose, and was connected by a β-glycosidic bond.

Accumulating evidence indicates antioxidant properties for numerous edible mushrooms, including D. indusiata, T. giganteum and P. cystidiosus (24,25). Kasuga et al (26) demonstrated that methanolic extracts from ear mushrooms exhibited marked reducing power in chelating ferrous ions and scavenging of DPPH and hydroxyl radicals. In addition, it has been reported that various extracts from H. marmoreus exerted antioxidant activities of 38.6–65.2% and a reducing power of 0.99 at a concentration of 5 mg/ml (27). Du et al (28) revealed that the chloroform extract derived from T. aurantialba fruiting bodies exhibited satisfactory antioxidant activity, and all chloroform, ethyl acetate and ethanol extracts exerted a greater scavenging activity on hydroxyl compared with superoxide anion radicals. However, less is known about the antioxidant activity of polysaccharides from T. aurantialba mycelium. In the present study, MCP obtained following fermentation exerted a greater reducing power compared with CMCP in the concentration range evaluated. Furthermore, MCP exhibited superior scavenging activities of DPPH and hydroxyl radicals compared with CMCP. These results indicate that the difference in antioxidant activities between MCP and CMCP may be associated with the total carbohydrate content.

Immunomodulatory effects have been associated with polysaccharides (29). The mechanism underlying immunoregulation primarily involves the induction of proliferation of various immune cells, including macrophages, lymphocytes and natural killer cells, and the stimulation of inflammatory mediator production by these cells (30). Therefore, proliferation assays are an appropriate method to rapidly screen the immunostimulatory activity of polysaccharides. Numerous reports have demonstrated the immunostimulatory activity of polysaccharides isolated from T. aurantialba. Lee et al (6) revealed that methanol soluble substances extracted from the fruiting body of T. aurantialba improved the activity of B lymphocytes, in which the alkaline phosphatase activity was increased 1.16-fold at the concentration of 200 µg/ml. Du et al (31) indicated that the acidic polysaccharide TAPA1 from T. aurantialba markedly stimulated the proliferation of murine lymphocytes in vitro in a dose-dependent manner. In the present study, 50–200 µg/ml MCP significantly increased proliferation of RAW264.7 macrophages. In addition, MCP exhibited a greater effect than LPS, while only 200 µg/ml CMCP promoted RAW264.7 cell proliferation.

Macrophages are important components of the immune system, which are crucial in host defense and acute inflammatory responses (32). NO, which is produced by macrophages, is an inorganic molecule that is critical in injury, inflammation and defense. Previous studies have indicated that polysaccharides stimulate NO production by macrophages, accompanied an improvement in immune function (33,34). Du et al (35) suggested that all polysaccharides (TAPA1, TAPA1-deac and TAPA1-ac) isolated from T. aurantialba fruiting bodies stimulated RAW264.7 macrophages to produce NO. In the present study, a significant increase in NO production was observed following treatment with >100 µg/ml MCP, compared with the negative control group (P<0.05). CMCP promoted NO production at the concentration of 200 µg/ml; however, this remained significantly reduced compared with MCP.

Following stimulation by various external factors, activated macrophages generate a variety of other mediators responsible for numerous homeostatic, immunologic and inflammatory processes, including IL-1, IL-6 and TNF-α. Therefore, cytokine production may be reflective of the inflammatory process and may provide a method to assess the effects of polysaccharide on macrophage activation. In the present study, 100 and 200 µg/ml MCP significantly upregulated the levels of IL-1, IL-6 and TNF-α produced by RAW264.7 macrophages, compared with the negative control group (P<0.05). CMCP induced only TNF-α production at a concentration of 200 µg/ml, with a reduced potency compared with MCP. Taken together, these results suggest that the total carbohydrate content in MCP and CMCP may contribute to differences in immunostimulatory activities.

In conclusion, CMCP was extracted from T. aurantialba mycelia following liquid fermentation. Purification by gel chromatography produced purified polysaccharide MCP. Compared with CMCP, MCP demonstrated significantly increased antioxidant and immunostimulatory activities. Due to the large difference in total carbohydrate content of MCP and CMCP, the findings of the present study suggest that increased total carbohydrate content may contribute to the increase in antioxidant and immunostimulatory activities. However, further studies are required to identify the mechanisms underlying the antioxidant and immunostimulatory activities of MCP, and to investigate the biological properties of MCP in vivo, to validate its potential clinical applications.

Acknowledgements

The present study was supported by the Research Fund for the Doctoral Program of Higher Education of China (grant no. 20110093110008) and the College Students' Innovative Training Program of Jiangnan University (grant no. 2015324Y).

References

1 

Bandoni RJ and Boekhout T: Tremelloid genera with yeast phases Fibulobasidium Bandoni, Holtermannia Saccardo & Traverso, Sirobasidium de Lagerheim & Patouillard, Tremella Persoon, Trimorphomyces Bandoni & OberwinklerThe Yeasts: A Taxonomic Study. Kurtzman CP and Fell JW: 4th. Elsevier B.V.; Amsterdam: pp. 705–717. 1998, View Article : Google Scholar

2 

Zhang Z, Li Y and Zhang K: Application of statistical analysis for the optimization of mycelia and polysaccharide production by Tremella aurantialba. Food Technol Biotechnol. 45:45–50. 2007.

3 

Zhang ZC, Lian B, Huang DM and Cui FJ: Compare activities on regulating lipid-metabolism and reducing oxidative stress of diabetic rats of Tremella aurantialba broth's extract (TBE) with its mycelia polysaccharides (TMP). J Food Sci. 74:H15–H21. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Ding Z, Li J, Liu J, Lu Y, Wang C and Zheng Q: Tremellin, a novel symmetrical compound, from the basidiomycete Tremella aurantialba. Helv Chim Acta. 85:882–884. 2002. View Article : Google Scholar

5 

Kiho T, Kochi M, Usui S, Hirano K, Aizawa K and Inakuma T: Antidiabetic effect of an acidic polysaccharide (TAP) from Tremella aurantia and its degradation product (TAP-H). Biol Pharm Bull. 24:1400–1403. 2001. View Article : Google Scholar : PubMed/NCBI

6 

Lee GW, Kim HY, Hur H, Lee MW, Shim MJ, Lee UY and Lee TS: Antitumor and immuno-modulatory effect of crude polysaccharides from fruiting body of Tremella aurantialba against mouse sarcoma 180. Korean J Mycol. 36:66–74. 2008. View Article : Google Scholar

7 

Wang H, Qu W, Chu S, Li M and Tian C: Studies on the preventive and therapeutic effects of the polysaccharide of Tremella aurantialba mycelia on diet-induced hyperlipidemia in mice. Acta Nutr Sin. 24:431–432. 2002.(In Chinese).

8 

Du XJ, Zhang JS, Yang Y, Tang QJ, Jia W and Pan YJ: Purification, chemical modification and immunostimulating activity of polysaccharides from Tremella aurantialba fruit bodies. J Zhejiang Univ Sci B. 11:437–442. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Kiho T, Kochi M, Usui S, Hirano K, Aizawa K and Inakuma T: Antidiabetic Effect of an Acidic Polysaccharide (TAP) from Tremella aurantia Schw.: Fr.(Heterobasidiomycetes) in Genetically Diabetic КК-Аy Mice. Int J Med Mushrooms. 4:115–123. 2002. View Article : Google Scholar

10 

Kiho T, Iguchi K, Usui S and Hirano K: Effect of Polysaccharides and 70% ethanol extracts from medicinal mushrooms on growth of human prostate cancer LNCaP and PC-3 Cells. Int J Med Mushrooms. 12:205–211. 2010. View Article : Google Scholar

11 

Du X, Zhang Y, Mu H, Lv Z, Yang Y and Zhang J: Structural elucidation and antioxidant activity of a novel polysaccharide (TAPB1) from Tremella aurantialba. Food Hydrocolloid. 43:459–464. 2015. View Article : Google Scholar

12 

Zhang W, Qu W, Zhang X, Deng Y and Zhu S: The anti-hyperglycemic activity of polysaccharides from Tremella aurantialba mycelium. Acta Nutr Sin. 26:300–303. 2003.(In Chinese).

13 

Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S and Lee YC: Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal Biochem. 339:69–72. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Sun Y, Wang H, Guo G, Pu Y and Yan B: The isolation and antioxidant activity of polysaccharides from the marine microalgae Isochrysis galbana. Carbohydr Polym. 113:22–31. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Chen Y, Xie M, Nie S, Li C and Wang Y: Purification, composition analysis and antioxidant activity of a polysaccharide from the fruiting bodies of Ganoderma atrum. Food Chem. 107:231–241. 2008. View Article : Google Scholar

16 

Deng C, Fu H, Teng L, Hu Z, Xu X, Chen J and Ren T: Anti-tumor activity of the regenerated triple-helical polysaccharide from Dictyophora indusiata. Int J Biol Macromol. 61:453–458. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Oyaizu M: Studies on products of browning reaction-antioxidative activities of products of browning reaction prepared from glucosamine. Jpn J Nutr Diet. 44:307–315. 1986. View Article : Google Scholar

18 

Rumbaoa R, Cornago D and Geronimo I: Phenolic content and antioxidant capacity of Philippine potato (Solanum tuberosum) tubers. J Food Compos Anal. 22:546–550. 2009. View Article : Google Scholar

19 

Thomas C, Mackey MM, Diaz AA and Cox DP: Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: Implications for diseases associated with iron accumulation. Redox Rep. 14:102–108. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Tiffen JC, Bailey CG, Ng C, Rasko JE and Holst J: Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo. Mol Cancer. 9:2992010. View Article : Google Scholar : PubMed/NCBI

21 

Ji Z, Tang Q, Zhang J, Yang Y, Jia W and Pan Y: Immunomodulation of RAW264. 7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J Ethnopharmacol. 112:445–450. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Kiho T, Kobayashi T, Morimoto H, Usui S, Ukai S, Hirano K, Aizawa K and Inakuma T: Structural features of an anti-diabetic polysaccharide (TAP) from Tremella aurantia. Chem Pharm Bull (Tokyo). 48:1793–1795. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Kiho T, Morimoto H, Kobayashi T, Usui S, Ukai S, Aizawa K and Inakuma T: Effect of a polysaccharide (TAP) from the fruiting bodies of Tremella aurantia on glucose metabolism in mouse liver. Biosci Biotechnol Biochem. 64:417–419. 2000. View Article : Google Scholar : PubMed/NCBI

24 

Mau JL, Chao GR and Wu KT: Antioxidant properties of methanolic extracts from several ear mushrooms. J Agri Food Chem. 49:5461–5467. 2001. View Article : Google Scholar

25 

Yang J, Lin H and Mau J: Antioxidant properties of several commercial mushrooms. Food Chem. 77:229–235. 2002. View Article : Google Scholar

26 

Kasuga A, Aoyagi Y and Sugahara T: Antioxidative activities of several mushroom extracts. Jpn Soc Food Sci Technol. 40:56–63. 1993. View Article : Google Scholar

27 

Lee Yu, Jian Shao, Lian Pei and Mau Jeng: Antioxidant properties of extracts from a white mutant of the mushroom Hypsizigus marmoreus. J Food Compos Anal. 21:116–124. 2008. View Article : Google Scholar

28 

Du XJ, Zhang JS, Liu YF, Tang QJ, Jia Z, Yang Z and Pan YJ: The antioxidant activity of various extracts from Tremella aurantialba fruiting bodies and their protective effects on PC 12 cells injured by oxidation. Acta Agri Shanghai. 26:49–52. 2010.

29 

Su Z, Dai Z and Yang J: Research progress on immune mechanism of polysaccharide. J Yunnan Agri Univ. 21:205–209. 2006.

30 

He Q and Zhang S: Advances in the studies on the mechanism of immuno-potentiation effect of polysaccharides from edible-medicinal fungi. Acta Edulis Fungi. 11:52–58. 2004.(In Chinese).

31 

Du X, Zhang J, Yang Y, Ye L, Tang Q, Jia W, Liu Y, Zhou S, Hao R, Gong C and Pan Y: Structural elucidation and immuno-stimulating activity of an acidic heteropolysaccharide (TAPA1) from Tremella aurantialba. Carbohyd Res. 344:672–678. 2009. View Article : Google Scholar

32 

Lee MY, Lee JA, Seo CS, Ha H, Lee H, Son JK and Shin HK: Anti-inflammatory activity of Angelica dahurica ethanolic extract on RAW264. 7 cells via upregulation of heme oxygenase-1. Food Chem Toxicol. 49:1047–1055. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Shin JY, Song JY, Yun YS, Yang HO, Rhee DK and Pyo S: Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharm immunot. 24:469–482. 2002. View Article : Google Scholar

34 

Lee KY and Jeon YJ: Macrophage activation by polysaccharide isolated from Astragalus membranaceus. Int Immunopharmacol. 5:1225–1233. 2005. View Article : Google Scholar : PubMed/NCBI

35 

Du X, Zhang J, Lv Z, Ye L, Yang Y and Tang Q: Chemical modification of an acidic polysaccharide (TAPA1) from Tremella aurantialba and potential biological activities. Food Chem. 143:336–340. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Deng C, Sun Y, Fu H, Zhang S, Chen J and Xu X: Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia. Mol Med Rep 14: 4857-4864, 2016.
APA
Deng, C., Sun, Y., Fu, H., Zhang, S., Chen, J., & Xu, X. (2016). Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia. Molecular Medicine Reports, 14, 4857-4864. https://doi.org/10.3892/mmr.2016.5794
MLA
Deng, C., Sun, Y., Fu, H., Zhang, S., Chen, J., Xu, X."Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia". Molecular Medicine Reports 14.5 (2016): 4857-4864.
Chicago
Deng, C., Sun, Y., Fu, H., Zhang, S., Chen, J., Xu, X."Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia". Molecular Medicine Reports 14, no. 5 (2016): 4857-4864. https://doi.org/10.3892/mmr.2016.5794
Copy and paste a formatted citation
x
Spandidos Publications style
Deng C, Sun Y, Fu H, Zhang S, Chen J and Xu X: Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia. Mol Med Rep 14: 4857-4864, 2016.
APA
Deng, C., Sun, Y., Fu, H., Zhang, S., Chen, J., & Xu, X. (2016). Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia. Molecular Medicine Reports, 14, 4857-4864. https://doi.org/10.3892/mmr.2016.5794
MLA
Deng, C., Sun, Y., Fu, H., Zhang, S., Chen, J., Xu, X."Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia". Molecular Medicine Reports 14.5 (2016): 4857-4864.
Chicago
Deng, C., Sun, Y., Fu, H., Zhang, S., Chen, J., Xu, X."Antioxidant and immunostimulatory activities of polysaccharides extracted from Tremella aurantialba mycelia". Molecular Medicine Reports 14, no. 5 (2016): 4857-4864. https://doi.org/10.3892/mmr.2016.5794
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team